This letter to the editor refers to, inter alia, the SOLIDARITY trial. SOLIDARITY chose to discontinue the HCQ arm because of "little or no reduction in the mortality of hospitalized COVID-19 patients".https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments …
-
This Tweet is unavailable.
-
-
This Tweet is unavailable.
-
Early or prophylactic use have been assessed as well, with high-quality trials having the exact same results. I'm really growing tired of this. There have been standards for proving drug efficacy for DECADES. If HCQ met those standards, we would not be having this conversation.
0 replies 0 retweets 5 likes -
This Tweet is unavailable.
-
And another
#Hydroxycholoroquine cultist can’t respond to the evidence that’s failed to find an effect against#COVID19.2 replies 1 retweet 17 likes -
This Tweet is unavailable.
-
Who’s “silencing” anyone? I’m merely answering misinformation with science. At least you admit now that you don’t have any decent science to cite.
1 reply 1 retweet 5 likes -
This Tweet is unavailable.
-
*could* have a role Hardly a slam-dunk.
2 replies 0 retweets 2 likes
Lots of questionable speculation, too.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.